ketanserin has been researched along with trazodone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Alhaider, AA; Mustafa, AA | 1 |
| Leff, P; Martin, GR | 1 |
| Freedman, M; Hamel, L; Luttinger, D; Perrone, M; Ward, SJ | 1 |
| Altuğ, U; Erol, D; Germiyanoğlu, C; Gürdal, M; Kurt, U; Ozkardeş, H | 1 |
| Giovannini, MG; Pazzagli, M; Pepeu, G | 1 |
1 trial(s) available for ketanserin and trazodone
| Article | Year |
|---|---|
The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction.
Topics: Adult; Aged; Double-Blind Method; Erectile Dysfunction; Humans; Ketanserin; Male; Mianserin; Middle Aged; Trazodone | 1994 |
10 other study(ies) available for ketanserin and trazodone
| Article | Year |
|---|---|
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Enhancement of imipramine-induced rat brain beta-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Brain Chemistry; Drinking Behavior; Female; Fenclonine; Imipramine; Isoproterenol; Ketanserin; Methysergide; Propranolol; Quipazine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Serotonin Antagonists; Trazodone; Zimeldine | 1991 |
Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists?
Topics: Animals; Aorta, Thoracic; In Vitro Techniques; Jugular Veins; Ketanserin; Male; Methysergide; Piperidines; Rabbits; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Spiperone; Trazodone | 1986 |
The effects of serotonin antagonists in a behavioral despair procedure in mice.
Topics: Animals; Behavior, Animal; Cyproheptadine; Guinea Pigs; Ketanserin; Male; Methysergide; Mice; Muscle, Smooth; Piperidines; Pizotyline; Rats; Rats, Inbred Strains; Receptors, Histamine; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Spiperone; Trazodone; Tritium | 1984 |
Trazodone increases extracellular serotonin levels in the frontal cortex of rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Carrier Proteins; Cerebral Cortex; Fluoxetine; Ketanserin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Trazodone | 1999 |